antihypertensive effect of 7-O-ethylfangchinoline (TJN-220) was analyzed in an experi mental model of hypertensive rats under the conscious condition. Single oral administration of TJN-220 (25 and 50 mg/kg) produced a progressive and long-lasting fall of mean blood pressure in spontaneously hypertensive rats (SHRs), deoxycorticosterone acetate (DOCA)-salt hypertensive rats and renal hyperten sive rats until 72 hr after the drug administration, but affected neither the heart rate in these hypertensive rats nor the hemodynamic parameters in normotensive rats. In SHRs implanted with a telemetry transmit ter, TJN-220 (50 mg/kg, p.o.) produced falls of systolic and diastolic blood pressures and diminished the difference in blood pressure between the dark period and the light period for 3 days, particularly by suppress ing the increasing phase of blood pressure during the dark period without influencing heart rate or locomotor activity. On the other hand, nicardipine (10 mg/kg, p.o.) produced a transient fall of blood pressure associated with a tachycardia during the light period on the first day alone. Clonidine (0.3 mg/kg, p.o.) diminished the increasing phases of blood pressure and heart rate during the dark period on the first day alone. Thus, the antihypertensive action of TJN-220 was much longer than those of nicardipine and clonidine. The present results suggest that TJN-220 may have potential for use as a beneficial antihyperten sive drug.
It has been reported that the rate of incidence of ad verse cardiovascular events such as myocardial infarc tion, sudden cardiac death and stroke increases in the early morning (1, 2) , and that possible causes for this tem poral dependence may involve the concomitant increases in blood pressure and heart rate (HR) (2) . Additionally, there is a proposal that the 24-hr mean value of blood pressure is the best prognostic indicator for cardiovascu lar events in hypertensive subjects (1, 3, 4) . Therefore, in the case of preclinical evaluation for drugs, it is important to clarify the influence of these drugs on diurnal patterns of arterial blood pressure, cardiac rhythm and their mean values over 24 hr. In China, tetrandrine, an alkaloid from the Chinese herb Radix Stephaniae tetrandrae, has been used to lower the blood pressure of hypertensive patients (5, 6) . Tetran drine has been presumed to be a calcium (Ca) antagonist on the basis of its pharmacological and electrophysiologi cal properties in isolated blood vessels or cardiac prepara tions (6) . With special attention to the duration of the antihypertensive effect, 7-O-ethylfangchinoline (TJN-220, Fig. 1 ), in which the methyl group at the 7-position of tetrandrine has been changed to an ethyl group, was syn thesized. This drug was reported to have effective hypoten sive action with relatively longer duration compared with several other derivatives of tetrandrine in spontaneously hypertensive rats (SHRs) without affecting plasma renin activity (7) . Although the mechanism of the antihyperten sive action of TJN-220 is unknown at present, prelimi nary experiments showed that TJN-220 non-specifically relaxed or inhibited contractions of isolated rat aorta in duced by high potassium, Bay K 8644, A23187 or phenyl ephrine (8) .
The purpose of this study is to determine the detailed profile of the antihypertensive effect of TJN-220 ad ministered orally (p.o.) in experimental hypertensive rats under the conscious condition. Therefore, we first exam ined the profiles of the antihypertensive effect of single oral administration of TJN-220 in SHRs, deoxycorti costerone acetate (DOCA)-salt hypertensive rats, renal hypertensive rats and normotensive rats. Secondly, by means of the biotelemetry system that can record simul taneously and continuously the blood pressure, HR and locomotor activity (ACT) in freely moving SHR for a long-term period, the effects of TJN-220, p.o. were ana lyzed and compared with those of nicardipine, a Ca an tagonist, and clonidine, an a2-adrenoceptor agonist, as reference drugs.
MATERIALS AND METHODS

Animals
Animals used in the present experiments were as fol lows: male SHRs (Charles River Japan, 22-week-old, Atsugi) and Sprague-Dawly (SD) rats (Charles River Japan, 5 to 10-week-old). Animals were housed over one week in cages with wood-chip bedding and were allowed free ac cess to tap water and a rat pellet diet under constant room temperature (23±2 C) and moisture (55±10%).
Preparation of renal hypertensive rats and DOCA-salt rats Renal hypertensive rats (RHRs): SD rats weighing 120 180 g (5-week-old) were anesthetized with ether. Renal hypertension was induced by placing a silver clip with an internal split distance of 0.2 mm around the left renal artery. The right renal artery was intact. These hypertensive rats were designated as the 2 kidney 1 clip renal hypertensive rats. Five to six weeks after this pro cedure when the systolic blood pressure (SBP) measured by the tail cuff method (PS-100; Riken Kaihatsu, Tokyo) reached above 190 mmHg, an arterial catheter for monitoring blood pressure was inserted under ether anesthesia.
DOCA-salt hypertensive rats (DOCA-salt rats): A left nephrectomy was performed under ether anesthesia on 6 week-old male SD rats weighed about 100 g. Two or three days after the left nephrectomy, the animals were sub cutaneously injected once a week with 25 mg/kg of DOCA in peanut oil solution and were given 1076 NaCl as drinking water. Six weeks after the DOCA injection when SBP measured by the tail cuff method reached above 190 mmHg, an arterial catheter was inserted under ether anesthesia.
Measurement of blood pressure
A polyethylene catheter was inserted into the lower abdominal aorta via the right femoral artery under ether anesthesia. The other end of the catheter was tunneled subcutaneously to exit the back of the neck and was an chored in place with silk strings. The catheter was filled with saline containing sodium heparin (200 U/ml), and a stainless steel wire was used to plug the open end of the catheter. Rats were housed in individual cages after sur gery and allowed free access to tap water and food. When rats recovered from surgical stress, the arterial catheter was connected to a pressure transducer (P231D, Statham, or P23XL, Spectramed; Oxnard CA, USA) for measure ment of blood pressure. Mean blood pressure (MBP) was obtained by electrically filtering the pulse pressure. HR was counted by means of a tachometer (1321; Nihon Denki San-ei, Tokyo) triggered by the pulse pressure signal. Blood pressure and HR under the conscious and unre strained condition were continuously recorded with a poly graph (363, Nihon Denki San-ei) during 12 hr after the drug administration; and the data at 24, 48 and 72 hr after were taken separately. Administration of TJN-220 was done about 3 hr after the start of measurement, since the animals instantly showed increases in blood pressure and HR just after the catheter was connected to a pres sure transducer.
Telemetry method
In the telemetry study, male SHRs (Charles River Japan, 30 to 40-week-old) were used. The light and dark periods were 12 hr each with lights on at 4:00 AM. Details of the telemetry system used in this study have been described previously (9, 10) . The system consists of 4 parts: a battery-operated transmitter, a receiver, a pres sure reference module and data acquisition software (Dataquest IV; Data Science Inc., St. Paul, MN, USA) running on an IBM PC/AT compatible computer. The battery-operated transmitter was placed in the abdominal cavity in each rat at least 7 days before the start of the experiment under ether anesthesia. Blood pressure was measured via the cannula inserted into the descending aorta. The output from the transmitter was monitored by the receiver. The telemetered pressure data were collected by a computer (386 AX; Kyosera, Tokyo) and then con verted to the unit of millimeters of mercury, which was subtracted by atmospheric pressure. The ACT of the rat was measured by electrically detecting changes in the posi tion of the implanted transmitter.
Sampling time of the pressure signal was 3 sec. SBP, dia 
RESULTS
Effects of TJN-220 on blood pressure and HR in experi mental hypertensive and normotensive rats Basal values of MBP, HR and body weight of hyper tensive and normotensive rats are summarized in Table 1 . There was no statistically significant difference in these values just before single oral administration of TJN-220 and vehicle in the 3 groups of hypertensive rats and nor motensive rats. Figures 2 and 3 show the time course of percent changes in MBP and HR after single oral adminis tration of TJN-220 in hypertensive rats and normotensive rats. In all types of hypertensive rats, TJN-220 (25 and 50 mg/kg, p.o.) dose-dependently produced a gradual and long-lasting fall of MBP. The nadir of MBP was seen from 8 to 12 hr after the drug administration, and then MBP gradually returned to the preadministration level until 72 hr after. Changes in HR after TJN-220 were not statistically different from those of each vehicle group in SHRs, DOCA-salt rats and renal hypertensive rats. There were some cases in which increases in MBP and HR were seen immediately after administrations of drug solutions and/or distilled water, which were probably due to stress occuring when the oral administration was performed.
In unrestrained normotensive rats (Fig. 3, right panel) , changes in MBP and HR induced by TJN-220 were simi lar to those by the vehicle. Effects of TJN-220 on blood pressure, HR, double pro duct and ACT in SHRs evaluated by the telemetry system In the vehicle group of SHRs implanted with the tele metry transmitter, SBP, DBP, HR, double product and ACT increased during the dark period compared with the light period, indicating the diurnal pattern of these parameters (Fig. 4) .
TJN-220 at 50 mg/kg, p.o. produced transient in creases in SBP, DBP, HR and double product followed by gradual and long-lasting decreases in SBP and DBP (Fig. 5) . Thus, TJN-220 diminished the increasing phases of SBP, DBP and double product during the dark period for 3 days, without influencing the diurnal variability of HR and ACT (Fig. 5) . In contrast to the case of TJN-220, nicardipine at 10 mg/kg (p.o.) produced a relatively short-lasting and marked hypotension associated with an apparent tachy cardia during the light period on the first day (Fig. 6 ), but did not affect the diurnal variability of SBP, DBP, double product and ACT on the first, second and third days. On the other hand, clonidine at 0.3 mg/kg, p.o. produced transient increases in SBP and DBP associated with a decrease in HR during the light period, followed by inhibitions of the increasing phases of SBP, DBP, HR, double product and ACT during the dark period on the first day, but these changes were not seen on the second and third days (Fig. 7) .
To analyze the data concerning diurnal variability numerically, effects of TJN-220, nicardipine and clonidine on the mean values of SBP, DBP, HR and ACT during the dark and light periods and data on the difference of these parameters between the light and dark periods on the first, second and third days after the drug administra tion are summarized in Table 2 . In the vehicle group, the light-dark differences of SBP, DBP, HR and ACT did not significantly change throughout the period of observa tion, although some alterations were seen in the mean values of HR themselves (Table 2) . TJN-220 at 50 mg/kg, p.o. significantly decreased mean values of SBP and DBP for 3 days and diminished the light-dark differences of SBP and DBP, while no significant change in HR and ACT was observed ( Table 2 ). As shown in Table 2 , nicardipine at 10 mg/kg, p.o. did not influence SBP, DBP and ACT for 3 days, but increased HR during the dark period on the second and third days concomitant with enlargement of the light-dark difference of HR. However, the present data could not explain these un expected changes in HR, since other hemodynamic parameters did not alter at all. In the case of clonidine at the dose of 0.3 mg/kg, p.o., SBP, DBP and HR were significantly suppressed on the first day, but suppressions of these parameters were recovered on the second day (Table 2 ). Although it seemed that ACT during the dark period on the first day was inhibited by clonidine, p.o. (Fig. 7) , the results in Table 2 showed that the change by clonidine was not statistically significant. 
DISCUSSION
The present study demonstrated that orally-admin istered TJN-220 produced a gradual and long-lasting fall of MBP in hypertensive rats such as SHRs, DOCA-salt rats and renal hypertensive rats, but not in normotensive rats. The characteristics that the antihypertensive ac tion appears more strongly in hypertensive animals than in normotensive animals has already been reported for nicardipine and benidipine, both Ca antagonists (11). Note that the data of the light period just after drug administration are excluded in order to evaluate the drug effect on the diurnal pattern. Values are means±S.E.M. *P<0.05, **P<0.01 vs. vehicle. +P<0.05, ++P<0.01 vs. each pre-administration value. SBP: systolic blood pressure, DBP: diastolic blood pressure, HR: heart rate, ACT: locomotor activity. Table 3 . Percent changes of the 24-hr mean values of systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and locomotor activity (ACT) from pre-administration values Similar experimental data were also obtained with the new dihydropyridine Ca antagonist CS-905 (12) . The metabolic disorders of Ca in the vascular smooth muscle of hypertensive animals have been suggested to be in volved in such specificity in cases of Ca antagonists (13). Since TJN has been reported to have Ca antagonistic action in an isolated vascular smooth muscle preparation (14) , the present results concerning the effects of TJN-220 on 3 types of hypertensive rats may be related to such a property. However, the detailed reason why TJN-220 lacks hypotensive action in normotensive rats remains to be explored.
It is well known that circadian rhythm of blood pres sure is found in normotensive subjects, and patients with mild or severe hypertension also exhibit this (15) . This cir cadian rhythm of blood pressure depends on endogenous neurohumoral factors in short-term changes within one day or during the sleep-wakefulness cycle (16) (17) (18) and/or depends on ACT (19) in long-term changes within one day. On the other hand, it has been reported that these patterns of blood pressure tend to disappear in hyperten sive patients, and high blood pressure tends to be main tained even during the sleep or night period (20, 21) . The telemetry system used in the present study allows continu ous recordings of blood pressure, HR and ACT under the almost normal or physiological state for long periods. Therefore, this system is considered to be useful for evalu ating the inflluence of medication on circadian rhythm.
As the rat is nocturnal, diurnal patterns show higher values of blood pressure, HR and ACT during the dark period than during the light period. Differently from hu man subjects, it has been reported that SHRs also reveal diurnal patterns, like normotensive rats do (22) . The present results ascertained that circadian rhythms of blood pressure, HR, double product and ACT of SHRs were dependent on the dark/light cycle. TJN-220 diminished the circadian rhythm of blood pressure for 3 days by strongly suppressing the increasing phase of blood pressure and double product during the dark period without influencing circadian rhythms of HR and ACT. The decreases in the 24-hr mean values of SBP and DBP seen for 3 days may indicate that TJN-220 has a long-lasting antihypertensive action.
Nicardipine, a dihydropyridine type of Ca antagonist, produced short-lasting and marked hypotension associat ed with an apparent tachycardia during part of the light period on the first day, suggesting that the duration of its effects is markedly shorter than that of TJN-220. Other data on nicardipine also showed the short-lasting property of this drug. Therefore, nicardipine hardly affected circa dian rhythms of blood pressure, HR, double product and ACT on the second and third days. On the other hand, clonidine produced the hypotensive effect along with a tend ency to suppress HR, double product and ACT, which was observed on the first day alone. These results suggest that clonidine may show its effect by an inhibitory action on the central nervous system. Therefore, it is unlikely that TJN-220 acts in a similar manner to clonidine, since the mode of action of TJN-220 on blood pressure, HR, double product and ACT was apparently different from that of clonidine. Judging from the 24 hr mean values of each hemodynamic parameter, the order of the duration of effects was TJN-220 (more than 3 days) > clonidine (one day) > nicardipine (less than half a day). A prelimi nary pharmacokinetic analysis showed that the serum con centration of TJN-220 gradually increased (Tmax: 12 hr) and then slowly diminished (T1,2: 24.3 hr). One of the rea sons for the long-lasting antihypertensive effect of TJN 220 may be the high drug concentration for a long period. The cause for the transient increase in blood pressure observed immediately after administration of TJN-220 could not be clarified by the present data alone, although clonidine is known to produce a transient increase in blood pressure through peripheral a2-adrenoceptor acti vation (23) . Otherwise, antihypertensive drugs such as nifedipine and other dihydropyridines often produce a tachycardia in clinical and experimental situations. This phenomenon is most probably due to the baroreceptor refllex caused by a rapid fall of blood pressure (24, 25) . In the present study, in contrast to the case of nicardipine, single oral administration of TJN-220 did not increase HR. The lack of a tachycardia may be partly attributed to the gradual onset of the hypotensive effect of TJN-220, because the degree of a tachycardia through the baro receptor reflex depends on the rate of fall of blood pressure rather than the level of hypotension (12, 26) . Since tetran drine was found to inhibit diltiazem binding in sarcolem mal vesicles from pig hearts (27) , it is also conceivable that TJN-220 may exert a negative chronotropic action through a diltiazem-like Ca antagonistic effect and there by could minimize the refllex tachycardia.
In this study, regardless of the sort of the drug, the changes in double product correlated well with those of HR and blood pressure. Since the double product was cal culated as the product of HR and SBP, the present results might be reasonable.
In conclusion, TJN-220 has a long-lasting antihyper tensive action without a refllex tachycardia, and the drug particularly suppresses the increasing phase of blood pres sure during the dark period without modifying diurnal patterns of HR and ACT. Thus, TJN-220 is expected to have potential for use as a beneficial antihypertensive drug.
